XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 16,145 $ 63,547
Investments in marketable securities 111,944 128,134
Trade receivables, net 101,458 109,964
Inventory 49,406 38,791
Prepaid manufacturing 16,019 17,880
Other prepaids and current assets 20,954 22,918
Total current assets 315,926 381,234
Property and equipment, net 7,724 8,754
Inventory, non-current 65,081 76,260
Goodwill and intangible assets 5,870 5,931
Other assets, non-current 7,825 8,668
Total assets 402,426 480,847
Current liabilities:    
Accounts payable 23,231 11,526
Accrued rebates, fees and reserves 55,697 54,461
Accrued compensation 12,422 22,610
Accrued and other current liabilities 32,057 50,097
Total current liabilities 123,407 138,694
Term loans 245,718 245,483
Convertible notes 225,900 225,575
Lease liabilities, non-current 3,806 5,046
Other liabilities, non-current 102 3,467
Total liabilities 598,933 618,265
Commitments and contingencies (Note 8)
Stockholders' deficit:    
Common stock ($0.0001 par value; shares authorized: 300,000,000; shares issued and outstanding: 80,488,296 and 78,851,516 at March 31, 2023 and December 31, 2022, respectively) 8 8
Additional paid-in capital 1,221,100 1,204,431
Accumulated other comprehensive loss (278) (249)
Accumulated deficit (1,417,337) (1,341,608)
Total stockholders' deficit (196,507) (137,418)
Total liabilities and stockholders' deficit $ 402,426 $ 480,847